See you next year in Munich, Germany | September 16-18, 2026
Join us for RNA Horizons 2026, taking place September 16-18, 2026, in Munich, Germany. This premier event unites leading researchers to explore the latest RNA therapeutic advancements, from established modalities to emerging areas like ASOs and RNA structure-based therapies. Discussions will encompass key trends: pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will address translating discoveries into viable therapies, exploring commercialization and market access.
Connect with leading scientists, clinicians and biotech innovators to explore the latest frontiers in RNA biology and therapeutic innovation.
This year’s conference will delve into the following key research areas:
- RNA Approaches in Rare, Pulmonary & Neurodegenerative Diseases
- Delivery Technologies and High-Throughput Discovery
- Splicing Mechanisms as Therapeutic Targets
- RNA Binding Proteins and Translational Control in Cancer
- RNA-Based Regulation as a Strategy for Immunotherapy
- Targeting Noncoding and Regulatory RNA Elements
RNA Horizons 2026 Organizing Committee
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Principal Investigator
Hebrew University-Hadassah Medical School, Jerusalem, Israel, and University of Pennsylvania, USA
Ernesto Guccione
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, USA
Claudio Sette
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Amalia Herszkowicz
Chief Operating Officer
Hadassah Cancer Research Institute, Israel
Our events
ORGANIZERS
2025 SPONSORS
2025 PARTICIPATING COMPANIES
